Pain and fatigue are two of the most prevalent and impactful symptoms experienced by patients afflicted with a wide range of common diseases and rare disorders. It is estimated that 10% of the world’s population is affected by chronic pain, disproportionally adversely affecting disadvantaged individuals, resulting in an enormous cost to society. Fatigue is a regular complaint, with a reported prevalence in the general population ranging from around 6 to 38 percent. One study estimated that the annual cost to employers in lost productivity due to fatigue exceeds $136 billion. 21 to 33 percent of patients report significant fatigue when visiting a primary care physician, resulting in approximately 7 million office visits per year in the United States. Moreover, the recognition of fatigue in healthcare providers and adequately addressing this issue is critically important to the assurance of optimal patient care.
Furthermore, there is growing concern about the overuse and abuse of prescription pain medications. Rates of opioid addiction are staggering. In one estimate, 1.7 million Americans age 12 and older abused pain medications in 2007. In a 2014 address to the Senate Caucus on International Narcotics Control, Nora D. Volkow, MD stated “It is estimated that between 26.4 million and 36 million people abuse opioids worldwide, with an estimated 2.1 million people in the United States suffering from substance use disorders related to prescription opioid pain relievers in 2012 and an estimated 467,000 addicted to heroin”. A recent article in the New York Times put it in perspective; "the addiction epidemic linked to [narcotic painkillers] has become the leading cause of injury death, surpassing motor vehicle fatalities in 2013, according to the Centers for Disease Control and Prevention." Cost effective and feasible alternatives to pharmaceutical interventions for the treatment and management of pain are critically needed.
For more information on the clinical perspective, refer to the problem description.
Designated Participant Roles wil help facilitate multidisciplinary team creation. Color-coded name tags identify participants' experience and interest.
Clinical healthcare professionals and trainees focused on patient-centered requirements, outcomes and feasibility
Biomedical scientists with analytical and biological expertise
Computer programmers with software design and development experience
Engineers and individuals focused on hardware design and development
Human factor engineers creating user interface and experience designs of the solution
|Concept Evaluation||Execution Evaluation|
|Clinical relevance & validity
||Overall software/hardware demo progress
|Potential clinical impact
||User Experience - usability and interface aesthetics
||Integration of technology
Each design criteria will be scored on a scale of 1 (Poor) to 5 (Excellent) and will be used to evaluate all project submissions. For more information on the design criteria, refer to the scoring guidelines.
Terms and Conditions
All participants must accept and adhere to the participation agreement. This agreement highlights and details many important characteristics of the event such as participant eligibility, juding criteria, and intellectual property.